Bolt Medical, Boston Scientific

Boston Scientific Surges On $900 Million Takeover Of Bolt Medical
Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.
Boston Scientific announces acquisition of the remaining stake in Bolt Medical
Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own.
Boston Scientific’s Strategic Acquisition of Bolt Medical Boosts Market Potential and Growth Opportunities
Patrick Wood, an analyst from Morgan Stanley, maintained the Buy rating on Boston Scientific (BSX – Research Report). The associated price
Boston Scientific makes IVL play with Bolt Medical acquisition
Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer Bolt Medical.
Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal
Boston Scientific to acquire Bolt Medical for $600 million upfront plus milestones. Bolt's IVL platform addresses coronary and peripheral artery disease.
Boston Scientific to acquire Bolt Medical for upfront payment of $443M
Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular
Boston Scientific to Buy Rest of Bolt Medical for $443 Million
Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery disease, for $443 million.
Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical
Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.
Boston Scientific Bolt Medical acquisition ‘checks right boxes,’ JPMorgan says
JPMorgan keeps an Overweight rating on Boston Scientific (BSX) with a $110 price target after the company announced an agreement to acquire the
Boston Scientific Corp. stock outperforms competitors on strong trading day
This was the stock's fifth consecutive day of gains.
Hosted on MSN4h
Boston Scientific price target raised to $110 from $100 at Bernstein
Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...
WBJournal14h
Boston Scientific to acquire California blood flow treatment manufacturer for up to $664M
Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...
Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Hosted on MSN12h
J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product
Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.